In line with the inflammatory signatures, the increased IRF5 expression in the adipose tissue of diabetic obese patients has been suggested as a potential marker for metabolic inflammation in obesity/T2D [73]. This evidence concerns the gene IRF5 and type 2 diabetes mellitus.